Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.
- DOI
- 10.3390/jpm16090479
- Published
- 2026 Sep 17
- Container
- Journal of personalized medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/jpm16090479,
title = {Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.},
author = {Arend RB and Peroni BZ and Lima NL and Cruz Garcia M and Koerich AH and do Nascimento AF and Dos Santos RTF and Tapia K and Kerpel D and Jung GS and Roman A and Gago G and da Silva MBC and Vial ADM and Agosti E},
year = {2026},
journal = {Journal of personalized medicine},
doi = {10.3390/jpm16090479},
url = {https://doi.org/10.3390/jpm16090479}
}RIS
TY - JOUR TI - Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives. AU - Arend RB AU - Peroni BZ AU - Lima NL AU - Cruz Garcia M AU - Koerich AH AU - do Nascimento AF AU - Dos Santos RTF AU - Tapia K AU - Kerpel D AU - Jung GS AU - Roman A AU - Gago G AU - da Silva MBC AU - Vial ADM AU - Agosti E PY - 2026 JO - Journal of personalized medicine DO - 10.3390/jpm16090479 UR - https://doi.org/10.3390/jpm16090479 ER -
APA
RB, A., BZ, P., NL, L., M, C. G., AH, K., AF, D. N., RTF, D. S., K, T., D, K., GS, J., A, R., G, G., MBC, D. S., ADM, V., & E, A. (2026). Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.. Journal of personalized medicine. https://doi.org/10.3390/jpm16090479
Source records
- pubmed · retrieved 2026-09-25T18:14:42.064Z